Navigation Links
Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008
Date:2/17/2009

ent (39,348) (23,096) Capitalization of intangible assets, including license and manufacturing access fees (11,970) (2,213) Proceeds from sale of investment in Molecular Profiling Institute, Inc. 4,100 - Other assets 27 (279) Net cash used in investing activities (139,888) (183,424) Financing activities: Excess tax benefit from employee stock options 2,493 14,606 Repurchase and retirement of restricted stock for payment of taxes (1,529) (1,474) Buyback of common stock (74,970) - Proceeds from issuance of common stock 20,472 48,680 Net cash (used in) / provided by financing activities (53,534) 61,812 Effect of exchange rate changes on cash and cash equivalents (672) 86 Net decrease in cash and cash equivalents (15,841) (11,942) Cash and cash equivalents at the beginning of period 75,963 87,905 Cash and cash equivalents at the end of period $60,122 $75,963


'/>"/>
SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash
2. Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
3. Eric Tardif Joins Gen-Probe as Senior Vice President, Corporate Strategy
4. Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
5. Gen-Probe to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference
6. Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance
7. Gen-Probe Announces Webcasts of Three Upcoming Investor Events
8. Gen-Probe to Webcast Two Upcoming Investor Presentations
9. Gen-Probe Announces Webcast of First Quarter 2008 Earnings Conference Call
10. Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference
11. Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... 2015 , ... Negative pressure wound therapy (NPWT) entails the ... exudates, fluid, and infectious materials to prepare the wound for healing and closure. ... canisters, etc.) is projected to expand continuously through 2021. , Rising patient and ...
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN in Houston, TX ... , an innovative vaginal health laser procedure that prevents and resolves dryness in ... atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, painful intercourse and ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... Screeners (NAPBS®) has announced that Edge Information Management has been granted ... Background Screening Credentialing Council (BSCC). , ÔÇťAchieving and maintaining this accreditation ...
(Date:9/1/2015)... Burlington, MA (PRWEB) , ... September 01, 2015 ... ... for remote real-time monitoring and analysis of pet vital signs and activity, today ... Cornerstone is one of the most popular and widely-adopted veterinary hospital Practice Management ...
(Date:9/1/2015)... ... September 01, 2015 , ... Discovia, ... entities, announced today that it has hired Scott Sanderson, an experienced business development ... capacity, Sanderson will be responsible for establishing and managing new client relationships in ...
Breaking Medicine News(10 mins):Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2
... second year in a row, survivors and generous souls alike ... Thriving Breast Fest Burlesque Show and Auction supporting the You ... burlesque show, silent auction and raffle, will take place on ... Hill,s in SoHo (511 Greenwich Street, NY). , All proceeds ...
... is one of five academic medical centers in the ... the University HealthSystem Consortium (UHC). The prestigious award is ... high-quality care, as measured by the UHC Quality and ... year, 93 member hospitals were ranked by UHC, a ...
... exists, experts say, , FRIDAY, Oct. 2 (HealthDay News) -- ... earlier treatment can begin. On that, experts agree. , ... odds of developing the degenerative brain disorder -- including some ... to figure it out: Do you or don,t you have ...
... Oct. 2 Amicus Therapeutics (Nasdaq: FOLD ) ... open-label study to assess the safety, tolerability and preliminary ... treatment-naive adult patients with type 1 Gaucher disease. ... on/four days off and seven days on/seven days off) ...
... long way in the last decade. Today, one can talk, text ... access the Web. Now imagine a cell phone that can be ... water quality after a major disaster like a hurricane or earthquake. ... at UCLA,s Henry Samueli School of Engineering and Applied Science, has ...
... remarkable history, role of dentists and reaffirms patient advocacy ... (ADA) yearlong observance of its 150th birthday will culminate with ... Waikiki Shell. , "The ADA,s 150th anniversary is a very ... Association," said ADA President John S. Findley, D.D.S. "It ...
Cached Medicine News:Health News:You Can Thrive! Burlesque Show Celebrates the Girls and the Women Who Are Battling to Keep Them 2Health News:University Hospitals Case Medical Center earns prestigious national award for excellence 2Health News:Uncertainty Surrounds Testing for Alzheimer's 2Health News:Uncertainty Surrounds Testing for Alzheimer's 3Health News:Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease 2Health News:Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease 3Health News:Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease 4Health News:Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease 5Health News:NIH recognizes engineering professor's innovative research with major award 2Health News:NIH recognizes engineering professor's innovative research with major award 3Health News:ADA Culminates Yearlong 150th Anniversary Observance at Its 150th Annual Session 2Health News:ADA Culminates Yearlong 150th Anniversary Observance at Its 150th Annual Session 3
(Date:9/1/2015)... , Sept. 1, 2015 ... held a press conference in Taipei ... in its new Vaucarrin™ platform, a targeted drug delivery ... This event was part of a joint ... Gold NanoTech Inc. (GNT), showcasing GNT,s latest edible ...
(Date:9/1/2015)... Sept. 1, 2015   Ivenix Inc. , ... management system, closed on a $42M round of ... Ventures. Cardinal Partners, CICA, Inc., Easterly Capital, Fidelity ... the round. This financing will support the company,s ... Leerink Partners LLC acted as the exclusive placement ...
(Date:9/1/2015)... , Sept. 1, 2015 CytRx Corporation ... development company specializing in oncology, today announced that ... Executive Officer, and David Haen , Vice ... present a corporate overview at two significant investment ... and healthcare industries: the FBR & Co. Second ...
Breaking Medicine Technology:GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4
... - Potential First-in-Class Treatment for Type 2 Diabetes ... Inc., a,biopharmaceutical company focused on the discovery and ... metabolic diseases,announced today that it has dosed the ... clinical trial of MBX-2982, a potential first-in-class treatment,for ...
... 25 ExonHit Therapeutics, a drug,and diagnostic discovery ... 1,study assessing the effects of its lead compound, ... EHT 0202 is a,compound, with a novel mechanism ... and neuronal loss and is currently tested in ...
Cached Medicine Technology:Metabolex Initiates Phase 1 Trial of MBX-2982 2ExonHit's EHT 0202 Counters Scopolamine's Detrimental Effects on Cognition in Humans 2ExonHit's EHT 0202 Counters Scopolamine's Detrimental Effects on Cognition in Humans 3ExonHit's EHT 0202 Counters Scopolamine's Detrimental Effects on Cognition in Humans 4
The MC-3 allows for simultaneous use of two lamps, with an additional built-in spare....
... a high light intensity. Light ... different brightness steps (Halogen 150) ... output can be adapted to ... small diameter scope, etc.). Different ...
Cold light source single outlet....
Cold light source single outlet....
Medicine Products: